missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Gibco™ Vitronectin (VTN-N) Recombinant Human Protein, Truncated
Vitronectin (VTN-N) is a recombinant human protein that provides a defined surface for feeder-free culture of human pluripotent stem cells (PSCs). When used with Essential 8™ Medium (A1517001), VTN-N has been proven to maintain pluripotency and normal growth characteristics in multiple PSC lines.
Brand: Gibco™ A14700
54.82 EUR valid until 2024-12-20
Use promo code "21651" to get your promotional price.
This item is not returnable.
View return policy
Description
- When used with Essential 8™ Medium (A1517001), vitronectin (VTN-N) has been proven to maintain pluripotency and normal growth characteristics in multiple PSC lines.
- Supports PSC growth for >50 passages without any signs of karyotypic abnormalities and to maintain the ability of PSCs to differentiate into all three germ line lineages.
- Supports human pluripotent stem cell attachment and survival better than wild-type vitronectin when used in conjunction with Essential 8™ Medium.
- Optimized—designed in the laboratory of James Thomson for use with Essential 8™ Medium
- Defined—for reduced variability in your PSC cultures
- Support human pluripotent stem cell attachment and survival better than wild type vitronectin.
- Optimal environment for feeder-free pluripotent stem cell culture.
- Defined, recombinant human protein that reduces variability in your PSC cultures compared to human-plasma derived vitronectin and standard basement membrane extracts (BMEs).
Specifications
500 μg⁄ml | |
HPLC | |
Human | |
Store at -80°C and protect from light. | |
Very Low | |
1 mL | |
Liquid | |
Stem Cell Research |
Stem Cell Culture | |
1 mL | |
Recombinant | |
AOF | |
Dry ice | |
Recombinant | |
Vitronectin | |
95 % |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only. Not for use in diagnostic procedures.
Spot an opportunity for improvement?Share a Content Correction